Business
Matricelf Ltd. (TASE: MTLF) Appoints Ron Mayron as Chairman of the Board
Matricelf Ltd. (TASE: MTLF), a biotechnology company developing autologous engineered tissue therapies, today announced the appointment of Mr. Ron Mayron as Active Chairman of the Board of Directors. Mr. Mayron's appointment follows shareholder approval and submission of his formal Director Eligibility Declaration in accordance with the Israeli Companies Law.
About this update from Matricelf Ltd.
[{"type":"text","content":"NESS ZIONA, Israel, Feb. 27, 2026 /PRNewswire/ -- Matricelf Ltd. (TASE: MTLF), a biotechnology company developing autologous engineered tissue therapies, today announced the appointment of Mr. Ron Mayron as Active Chairman of the Board of Directors. Mr. Mayron's appointment follows shareholder approval and submission of his formal Director Eligibility Declaration in accordance with the Israeli Companies Law.","length":420,"tagName":"p"},{"type":"image","alt":"Ron Mayron, Chairman of the Board of Matricelf","displaySize":"","headline":null,"caption":"Ron Mayron, Chairman of the Board of Matricelf","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/9f0ea873303f7a798dd55a0f693f0b8a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/r7WlJyKrVQyj565wSpyBqg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/9f0ea873303f7a798dd55a0f693f0b8a","width":400,"height":400}},"href":"https://mma.prnewswire.com/media/2921260/Ron_Mayron.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Extensive Leadership and Industry Experience","length":44,"tagName":"p"},{"type":"text","content":"Mr. Mayron holds a BSc in Industrial Engineering and Management from Ben Gurion University and an MBA from Tel Aviv University. He has served as CEO and owner of RonMed Ltd. since 2015 and brings decades of executive leadership experience in the healthcare and life sciences sectors. Over the past 5 years, Mr. Mayron has served as a director in multiple public and private life sciences companies, including SimpliVity, InnoCan Pharma, IceCure Medical, BioLight, G Medical, Kadimastem, Entera Bio, DNA Biomedical Solutions, and Earmada . His broad board level experience spans biotechnology, medical devices, pharmaceuticals, and advanced therapeutic platforms. In his eligibility declaration, Mr. Mayron confirmed that he meets the statutory qualifications to serve as a director of a public company under Israeli law and that he is not classified as a director with accounting and financial expertise. He also confirmed that he does not hold shares or convertible securities of the Company at the time of appointment.","length":1020,"tagName":"p"},{"type":"text","content":"Strengthening Corporate Governance","length":34,"t...